Skip to main content

Table 1 Laboratory data

From: Plasma exchange for thrombotic microangiopathy secondary to dermatomyositis associated with acute kidney injury and complement activation: a case report with literature review

Hematology

 WBC

18,000

/μL

  Neut

92

%

  Ly

3

%

 RBC

268 × 104

/μL

 Hemoglobin

7.9

g/dL

 Platelet

19,000

/μL

 Fragmentation

+

 

 Haptoglobin

< 10

mg/dL

 ADAMTS13

  Activity

17.8

%

  Inhibitor

–

 

 Direct Coombs’ test

–

 

 Indirect Coombs’ test

–

 

Biochemistry

 TP

6.0

g/dL

 Alb

2.0

g/dL

 BUN

32

mg/dL

 Cre

0.6

mg/dL

 Na

120

mEq/L

 K

6.1

mEq/L

 Cl

89

mEq/L

 LDH

1942

IU/L

 AST

260

IU/L

 ALT

138

IU/L

 CK

9823

IU/L

 Myoglobin (≦ 154.9)

307.3

ng/mL

 Ferritin (12–60)

876

ng/mL

Serology

 CRP

0.27

mg/dL

 C3

65

mg/dL

 C4

14

mg/dL

 CH50

32.6

U/mL

 ANA

< 40x

 

 Anti-DNA Ab

–

 

 Anti-Jo-1 Ab

–

 

 Anti-ARS Ab

PL-12 +

 

 Anti-factor H Ab

–

 

Coagulation

 PT-INR

1.07

 

 APTT (24–40)

39.3

sec

 Fibrinogen

252

mg/dL

 FDP

12.4

μg/mL

 D-dimer

5.74

μg/mL

Urinalysis

 pH

5.5

 

 Protein

1+

 

 Glucose

–

 

 Occult blood

2+

 

 Sediment

  RBC

10–19

/hpf

  WBC

1–4

/hpf

  Cast

–

 

 Myoglobin (≦ 10)

110

ng/mL

  1. WBC, leukocytes; RBC, erythrocytes; Neu, neutrophil; Ly, lymphocyte; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cre, creatinine; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatine kinase; CRP, C-reactive protein; ANA, anti-nuclear antibody; Ab, antibodies; ARS, aminoacyl-tRNA synthetase; PT, prothrombin time; APTT, activated partial thromboplastin time; FDP, fibrin degradation products; hpf, high-power field